Quimioterapia intensiva con soporte de progenitores hematopoyéticos en neoplasias sólidas no hematológicas de la edad pediátrica: Indicaciones y estado actual del tema

Translated title of the contribution: Intensive chemotherapy with stem cell support in non-hematological pediatric solid tumors: State of the art

Soledad Gallego Melcón*, José Sánchez De Toledo Codina

*Corresponding author for this work

Research output: Contribution to journalReview articleResearchpeer-review

1 Citation (Scopus)

Abstract

High-dose chemotherapy with autologous bone marrow or peripheral stem cell support is frequently used for the treatment of high-risk pediatric solid tumors. The gained experience with these treatments runs parallel with a considerable decrease on the procedure- related complications. These strategies have demonstrated its efectivity in the treatment of high-risk neuroblastoma as well as in refractory or relapsed germ cell tumors. There are also evidences showing that its use in high-risk Ewing's sarcoma, and in chemosensitive relapsed or metastatatic brain tumors, contributes to ameliorate the dismal prognosis of these patients.

Translated title of the contributionIntensive chemotherapy with stem cell support in non-hematological pediatric solid tumors: State of the art
Original languageSpanish
Pages (from-to)5-10
Number of pages6
JournalClinical and Translational Oncology
Volume3
Issue number1
Publication statusPublished - Jan 2001

Fingerprint Dive into the research topics of 'Intensive chemotherapy with stem cell support in non-hematological pediatric solid tumors: State of the art'. Together they form a unique fingerprint.

Cite this